Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGMS Analysis of Glimepiride Add-on to Metformin in T2DM
NCT00633425Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of glimepiride in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Oct 2002; status: completed.
02
Drugs
glimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00633425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633425.